002099 Stock Overview
Operates as a pharmaceutical company in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Zhejiang Hisoar Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.91 |
| 52 Week High | CN¥7.33 |
| 52 Week Low | CN¥3.91 |
| Beta | 0.55 |
| 11 Month Change | -2.15% |
| 3 Month Change | 8.84% |
| 1 Year Change | -16.17% |
| 33 Year Change | -23.94% |
| 5 Year Change | -14.60% |
| Change since IPO | -34.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002099 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.2% | -1.8% | -2.6% |
| 1Y | -16.2% | -7.0% | 4.2% |
Return vs Industry: 002099 underperformed the CN Pharmaceuticals industry which returned -6% over the past year.
Return vs Market: 002099 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 002099 volatility | |
|---|---|
| 002099 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002099 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002099's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1966 | 2,612 | Guorui Xu | www.hisoar.com |
Zhejiang Hisoar Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers antibiotics, cardiovascular products, hypoglycemic products, fine chemicals, dyes, intermediates, and other products, as well as clindamycin products. It also provides pharmaceutical, dyestuff, and other related services.
Zhejiang Hisoar Pharmaceutical Co., Ltd. Fundamentals Summary
| 002099 fundamental statistics | |
|---|---|
| Market cap | CN¥9.38b |
| Earnings (TTM) | -CN¥369.49m |
| Revenue (TTM) | CN¥1.94b |
4.8x
P/S Ratio-25.4x
P/E RatioIs 002099 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002099 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.94b |
| Cost of Revenue | CN¥1.68b |
| Gross Profit | CN¥259.34m |
| Other Expenses | CN¥628.82m |
| Earnings | -CN¥369.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 13.37% |
| Net Profit Margin | -19.05% |
| Debt/Equity Ratio | 20.3% |
How did 002099 perform over the long term?
See historical performance and comparison